(Q34269604)

1 August 2017

1 reference

title

Cholesterol-receptor-mediated genomics in health and disease (English)

1 reference

1 August 2017

Deepak Kaul

1

1 reference

1 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14557057

21 March 2024

publication date

1 October 2003

1 reference

full work available at URL

1 August 2017

https://api.elsevier.com/content/article/PII:S1471491403001916?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

https://api.elsevier.com/content/article/PII:S1471491403001916?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Trends in Molecular Medicine

21 March 2024

published in

1 reference

1 August 2017

volume

9

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

442-449

1 reference

Coronary heart disease — The global picture

1 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Cholesterol inhibition, cancer, and chemotherapy

21 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

A receptor-mediated pathway for cholesterol homeostasis

21 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Regulation of the mevalonate pathway

21 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

The molecular biology of apoptosis

21 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages

21 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Why are low-density lipoproteins atherogenic?

21 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Low density lipoprotein undergoes oxidative modification in vivo

21 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Receptor-Ck and leukemogenesis

21 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Molecular link between cholesterol, cytokines and atherosclerosis

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Lymphocytes from CML patients lack a 47 kDa factor having affinity for a genomic sterol regulatory sequence

21 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Sterol dependent LDL-receptor gene transcription in lymphocytes from normal and CML patients

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Receptor-'Ck' dependent signalling regulates the LDL-receptor gene transcription

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism

21 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Receptor-Ck-dependent regulation of genes involved in the cell cycle

21 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27)

21 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Regulation of PPAR-gamma gene in human promyelocytic HL-60 cell line

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

The PPARs: from orphan receptors to drug discovery

21 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Molecular medicine. The cholesterol quartet

21 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

New insights into the role of nuclear factor-KB, a ubiquitous transcription factor in the initiation of diseases

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Peroxisome proliferator-activated receptors in the cardiovascular system

21 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

21 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

21 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

21 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells

21 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

21 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet

21 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis

21 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

21 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Twin studies of coronary heart disease and its risk factors

21 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

BCL2 gene: current relevance to clinical oncology

21 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

21 March 2024

Apoptosis and disease.

45

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

The control of hematopoiesis and leukemia: from basic biology to the clinic

21 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

21 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity

21 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Epithelial cells as sensors for microbial infection

21 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

21 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Cholesterol starvation induces differentiation of the intestinal parasite Giardia lamblia

21 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Receptor-Ck regulates giardia encystation process

21 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Essential role for cholesterol in entry of mycobacteria into macrophages

21 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression

21 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

21 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.MOLMED.2003.08.010

21 March 2024

Identifiers

1 reference

1 August 2017

1 reference